A Mississippi city councilman agreed to forfeit a monster truck and nearly $2 million after a federal investigation revealed he sold illicit drugs advertised as CBD, prosecutors announced Thursday.
Robert Leon Deming, III, who serves on the Biloxi City Council, sold over $2 million in illegal synthetic cannabinoids as vape additives that he labeled as CBD, the U.S. Attorney’s Office said following a yearslong probe by the Drug Enforcement Administration. The DEA received complaints in 2022 that customers became ill after using some of Deming’s products, and his employees discussed in group chats how the additives were too strong and could hurt customers, according to prosecutors.
“A public official’s side job should not be running a business that distributes millions of dollars in illegal controlled substances and endangers the health and safety of its customers,” said U.S. Attorney Todd Gee. “We appreciate the hard work of investigators with the DEA, FDA, and MBN to put a stop to the distribution of these dangerous vape additives.”
Feds launched probe into Deming’s business one year after it opened
According to court documents, Deming founded the Candy Shop LLC in 2019 and opened stores in Mississippi and North Carolina. In 2020, the Mississippi Bureau of Narcotics and DEA launched an investigation into his business and found some of the vape products contained illicit additives.
In May 2022, federal prosecutors said Deming gave someone $2,200 to buy about two pounds of a synthetic cannabinoid product known as 5F-AB-PINACA to use in the shop’s vape additives. Investigators also found that Deming’s gross sales of vape additive products containing illegal drugs totaled over $2 million. He was arrested in September and released days later on bond, according to court records.
Deming pleaded guilty to conspiracy to possess with intent to distribute a controlled substance, punishable by up to 20 years in prison and $1 million penalty. As part of the plea agreement, he agreed to forfeit a yellow monster truck with oversized tires, a lift kit, and nearly $2 million.
“Mr. Deming pleaded guilty to one count of conspiracy in what amounted to a very complicated case hinging upon his knowledge of the existence of synthetic cannabinoids in vape products he sold along with other allegations by the Government,” attorney W. F. Hornsby III told USA TODAY on Thursday. “Mr. Deming’s decision to plead guilty was made after taking into consideration his family, friends, employees, and the totality of the circumstances.”
His sentencing is scheduled for Aug. 13.
Synthetic cannabinoids
Synthetic cannabinoids, such as the one Deming was caught using as vape additives, are a class of lab-made drugs that have similar chemicals to the cannabis plant, according to the National Institute on Drug Abuse. The drug can be cheaper to make and is more likely to go undetected in urine drug screenings, the institute said, but it can cause starkly different reactions compared to natural cannabis products.
Some synthetic cannabinoids are classified under the Controlled Substances Act as Schedule I drug, alongside marijuana, heroin, and LSD. The act categorizes drugs based on their potential for abuse, addiction, and medical use.
What is CBD?
Cannabidiol, or CBD, is a chemical extracted from cannabis plants. It can be found in both hemp and marijuana plants — both are technically cannabis but hemp must have less than 0.3% THC present. CBD is non-psychoactive and shouldn’t contain THC, the chemical that produces the “high” feeling in marijuana.
The usual CBD formulation is oil, but it is also sold as an extract, vaporized liquid, and oil-based capsule, according to the Mayo Clinic. Food, drinks, and beauty products are among the many CBD-infused products available online, including lip balms, gummies, and creams.
Side effects of CBD may include dry mouth, diarrhea, reduced appetite, drowsiness, and fatigue, the Mayo Clinic warned. The chemical can also interact with other medications. If you have a heart condition or take blood thinners, some doctors recommend staying away from CBD.
Contributing: Marina Pitofsky, USA TODAY